Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

246
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
246
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

820
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
820
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

476
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
476
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

831
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
831
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

585
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
585

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prescription Contraception Use Among Psychiatric Inpatients.

Psychiatric services (Washington, D.C.)·2026
Same author

On the Spectrum: High-Functioning Autism and Its Contemporary Relevance.

Mayo Clinic proceedings·2026
Same author

Adjunctive xanomeline/trospium in clozapine-resistant schizophrenia: two case reports demonstrating limited response.

Therapeutic advances in psychopharmacology·2026
Same author

SGLT2 Inhibitors Associated With Improved Kidney Function in Lithium-Treated Patients With Mood Disorders: A Real-World Historical Cohort Study.

Bipolar disorders·2026
Same author

Question: Do GLP-1 and Dual GIP/GLP-1 Agonists Interact With Lithium, and What Are the Monitoring Implications?

Journal of clinical psychopharmacology·2026
Same author

Lithium toxicity following a change from semaglutide to tirzepatide for weight loss management.

The mental health clinician·2026

Related Experiment Video

Updated: Jan 18, 2026

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

9.3K

Psychotropic Medications for Non-Psychiatric Conditions: A Narrative Review.

Melanie T Gentry1, Jonathan G Leung2, Laura Suarez1

  • 1Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Healthcare (Basel, Switzerland)
|September 13, 2025
PubMed
Summary

Psychotropic medications (PMs) offer significant benefits beyond psychiatric care, treating various medical conditions. Understanding their full utility and risks is crucial for all physicians to optimize patient outcomes.

Keywords:
drug interactionspolypharmacypsychopharmacology

More Related Videos

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.0K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.6K

Related Experiment Videos

Last Updated: Jan 18, 2026

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

9.3K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.0K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.6K

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Neuroscience

Background:

  • The classification of medications as solely psychiatric or psychotropic is often arbitrary, limiting the recognition of their broader clinical applications.
  • Psychotropic medications (PMs) possess pharmacologic activities that extend beyond mental health treatment.

Purpose of the Study:

  • To review the non-psychiatric indications for psychotropic medications.
  • To highlight the benefits and risks of using PMs for medical conditions.
  • To provide guidance for prescribers on optimizing the use of PMs in diverse clinical settings.

Main Methods:

  • Literature review examining the pharmacologic effects of PMs on neurotransmitters.
  • Analysis of therapeutic outcomes and adverse effects in non-psychiatric applications.
  • Synthesis of guiding principles for safe and effective prescribing.

Main Results:

  • PMs are utilized across various specialties, including neurology, dermatology, and pain management.
  • Understanding neurotransmitter interactions is key to both efficacy and side effects.
  • Dose adjustment, age considerations, and polypharmacy management are critical.

Conclusions:

  • Physicians should recognize the extensive non-psychiatric utility of PMs.
  • Awareness of full pharmacologic profiles enhances clinical decision-making.
  • Adherence to guiding principles ensures safe and effective use of PMs for medical indications.